Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 30

Results For "BAL-Pharma"

387 News Found

Merck opens microbiology application lab in Jigani, Bengaluru
Diagnostic Center | July 24, 2022

Merck opens microbiology application lab in Jigani, Bengaluru

Merck’s first microbiology application and training lab in India


Lupin Diagnostics launches its first reference laboratory in Ranchi
Diagnostic Center | July 19, 2022

Lupin Diagnostics launches its first reference laboratory in Ranchi

Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies


Avet Pharmaceuticals appoints George Svokos as President &CEO
People | July 18, 2022

Avet Pharmaceuticals appoints George Svokos as President &CEO

George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies


Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray
Diagnostic Center | July 14, 2022

Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray

The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.


Glenmark Pharma launches Minym Gel for acne treatment
News | July 11, 2022

Glenmark Pharma launches Minym Gel for acne treatment

MINYM can be safely used by patients above 9 years of age.


Piramal Pharma strengthens board by inducting three new board members
People | July 11, 2022

Piramal Pharma strengthens board by inducting three new board members

The appointments will add to the well-diversified experience that currently exists on the PPL board.


Lupin’s Somerset manufacturing plant Receives EIR from US FDA
Drug Approval | July 08, 2022

Lupin’s Somerset manufacturing plant Receives EIR from US FDA

The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated


Glenmark launches Sitagliptin and its FDC at affordable price
News | July 08, 2022

Glenmark launches Sitagliptin and its FDC at affordable price

These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens


Time to move from ‘Volume’ to ‘Value’ leadership to capture global market, says Mandaviya
Policy | July 03, 2022

Time to move from ‘Volume’ to ‘Value’ leadership to capture global market, says Mandaviya

Govt committed to supporting pharma companies with industry-friendly policies


Lupin receives approval from USFDA for Paliperidone extended-release tablets
Drug Approval | July 01, 2022

Lupin receives approval from USFDA for Paliperidone extended-release tablets

Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S